Invention Grant
- Patent Title: Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods
-
Application No.: US12029425Application Date: 2008-02-11
-
Publication No.: US08409607B2Publication Date: 2013-04-02
- Inventor: Patrick M. Hughes , Thomas C. Malone , Gerald W. De Vries , Jeffery L. Edelman , Joan-En Chang-Lin , Jane-Guo Shiah , Thierry Nivaggioli
- Applicant: Patrick M. Hughes , Thomas C. Malone , Gerald W. De Vries , Jeffery L. Edelman , Joan-En Chang-Lin , Jane-Guo Shiah , Thierry Nivaggioli
- Applicant Address: US CA Irvine
- Assignee: Allergan, Inc.
- Current Assignee: Allergan, Inc.
- Current Assignee Address: US CA Irvine
- Agent Louis V. Wollenberger; Joel B. German; Debra D. Condino
- Main IPC: A61F2/02
- IPC: A61F2/02
Abstract:
Biocompatible intraocular implants include a tyrosine kinase inhibitor and a biodegradable polymer that is effective to facilitate release of the tyrosine kinase inhibitor into an eye for an extended period of time. The therapeutic agents of the implants may be associated with a biodegradable polymer matrix, such as a matrix that is substantially free of a polyvinyl alcohol. The implants may be placed in an eye to treat or reduce the occurrence of one or more ocular conditions.
Public/Granted literature
- US20080254096A1 SUSTAINED RELEASE INTRAOCULAR IMPLANTS CONTAINING TYROSINE KINASE INHIBITORS AND RELATED METHODS Public/Granted day:2008-10-16
Information query
IPC分类:
